Cystic fibrosis and portal hypertension: Distal splenorenal shunt can prevent the need for future liver transplant

2019 ◽  
Vol 54 (5) ◽  
pp. 1076-1082 ◽  
Author(s):  
Caroline Lemoine ◽  
Joan Lokar ◽  
Susanna A. McColley ◽  
Estella M. Alonso ◽  
Riccardo Superina
2008 ◽  
Vol 32 (3) ◽  
pp. 483-487 ◽  
Author(s):  
Suk-Bae Moon ◽  
Sung-Eun Jung ◽  
Jong-Won Ha ◽  
Kwi-Won Park ◽  
Jeong-Kee Seo ◽  
...  

1990 ◽  
Vol 14 (1) ◽  
pp. 115-121 ◽  
Author(s):  
Gian Paolo Spina ◽  
Roberto Santambrogio ◽  
Enrico Opocher ◽  
Filippo Gattoni ◽  
Umberto Baldini ◽  
...  

1999 ◽  
Vol 15 (2) ◽  
pp. 92-96 ◽  
Author(s):  
T. Hasegawa ◽  
H. Tamada ◽  
Y. Fukui ◽  
H. Tanano ◽  
A. Okada

Surgery Today ◽  
2002 ◽  
Vol 32 (8) ◽  
pp. 727-730 ◽  
Author(s):  
Tatsuya Kato ◽  
Hiroyuki Kato ◽  
Satoshi Kondo ◽  
Shunichi Okushiba ◽  
Toshiaki Morikawa

2007 ◽  
Vol 135 (5-6) ◽  
pp. 293-297 ◽  
Author(s):  
Predrag Gajin ◽  
Bozina Radevic ◽  
Dragoslav Nenezic ◽  
Nenad Ilijevski ◽  
Rada Jesic-Vukicevic ◽  
...  

Introduction: Hypersplenism is a common complication of portal hypertension. Cytopenia in hypersplenism is predominantly caused by splenomegaly. Distal splenorenal shunt (Warren) with partial spleen resection is an original surgical technique that regulates cytopenia by reduction of the enlarged spleen. Objective. The aim of our study was to present the advantages of distal splenorenal shunt (Warren) with partial spleen resection comparing morbidity and mortality in a group of patients treated by distal splenorenal shunt with partial spleen resection with a group of patients treated only by a distal splenorenal shunt. Method. From 1995 to 2003, 41 patients with portal hypertension were surgically treated due to hypersplenism and oesophageal varices. The first group consisted of 20 patients (11 male, mean age 42.3 years) who were treated by distal splenorenal shunt with partial spleen resection. The second group consisted of 21 patients (13 male, mean age 49.4 years) that were treated by distal splenorenal shunt only. All patients underwent endoscopy and assessment of oesophageal varices. The size of the spleen was evaluated by ultrasound, CT or by scintigraphy. Angiography was performed in all patients. The platelet and white blood cell count and haemoglobin level were registered. Postoperatively, we noted blood transfusion, complications and total hospital stay. Follow-up period was 12 months, with first checkup after one month. Results In the first group, only one patient had splenomegaly postoperatively (5%), while in the second group there were 13 patients with splenomegaly (68%). Before surgery, the mean platelet count in the first group was 51.6?18.3x109/l, to 118.6?25.4x109/l postoperatively. The mean platelet count in the second group was 67.6?22.8x109/l, to 87.8?32.1x109/l postoperatively. Concerning postoperative splenomegaly, statistically significant difference was noted between the first and the second group (p<0.05). Comparing the postoperative platelet count between the first and second group, we found that there was a very significant statistical difference, too (p<0.01). Conclusion. Distal splenorenal shunt (Warren) with partial spleen resection is a very reliable surgical technique in treatment of hypersplenism and decompression of oesophageal varices caused by portal hypertension and has advantage in treatment of hypersplenism over the distal splenorenal shunt method. .


2021 ◽  
Vol 8 ◽  
Author(s):  
Qigu Yao ◽  
Wenyi Chen ◽  
Cuilin Yan ◽  
Jiong Yu ◽  
Tian'an Jiang ◽  
...  

Background and Aims: Viral hepatitis are one of the main causes of liver cirrhosis. The treatment of portal hypertension caused by liver cirrhosis is difficult and diverse, and the therapeutic effect is unknown. Bayesian network meta-analysis was performed to compare the efficacy and safety of treatments for patients with portal hypertension and cirrhosis, including a transjugular intrahepatic portosystemic shunt (TIPS), endoscopic therapy, surgical therapy and medications.Methods: Eligible articles were searched for in PubMed, Embase, Cochrane Library and Web of Science databases from their inception until June 2020. Using the “gemtc-0.8.4” package in R v.3.6.3 software and the Just Another Gibbs Sampler v.4.2.0 program, network meta-analysis was performed using a random effects model within a Bayesian framework. The odds ratios for all-cause rebleeding, bleeding-related mortality, overall survival (OS), treatment failure and hepatic encephalopathy were determined within the Bayesian framework.Results: Forty randomized controlled trials were identified, including 4,006 adult patients and nine treatment strategies. Our results showed that distal splenorenal shunt and TIPS provided the best control of hemorrhage. Endoscopic variceal ligation with medication resulted in the highest OS rate. Medication alone resulted in poor OS and treatment failure.Conclusions: We performed a systematic comparison of diverse treatments for cirrhotic patients with portal hypertension. Our meta-analysis indicated that a TIPS and distal splenorenal shunt resulted in lower rates of rebleeding than did other therapies. Furthermore, drugs are more suitable for combination therapy than monotherapy.


Sign in / Sign up

Export Citation Format

Share Document